Pharvaris N.V.
(PHVS - NASDAQ)
32,02 USD
📋 Profilo Aziendale

Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.

|